Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 38Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma 16Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, Non-Hodgkin 15Myelodysplastic Syndromes 14Lymphoma, Mantle-Cell 14Lymphoma, Follicular 14Lymphoma, B-Cell, Marginal Zone 12Congenital Abnormalities 12Lymphoma, Large B-Cell, Diffuse 10Hodgkin Disease 10Burkitt Lymphoma 10Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myelomonocytic, Chronic 8Multiple Myeloma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Myeloproliferative Disorders 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Hematologic Neoplasms 6Dendritic Cell Sarcoma, Interdigitating 6Blast Crisis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Neoplasms, Plasma Cell 4

Interventions

Cyclophosphamide 30fludarabine phosphate 25Cyclosporine 25Busulfan 20Mycophenolic Acid 18Peripheral Blood Stem Cell Transplantation 17Cord Blood Stem Cell Transplantation 16Antilymphocyte Serum 16Whole-Body Irradiation 15Radiotherapy 15Methotrexate 12Methylprednisolone 10Filgrastim 10Cytarabine 8Etoposide 7Tacrolimus 6Melphalan 6sargramostim 5fludarabine 4Thiotepa 4Granulocyte Colony-Stimulating Factor 4Decitabine 4Cyclosporins 4Azacitidine 4merphos 3Transplantation 3Arsenic Trioxide 3bryostatin 1 2aldesleukin 2Vorinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia, Refractory × aldesleukin × Other hematologic neoplasm × Clear all
NCT00002746 2019-02-27

Interleukin-2 in Treating Patients With Myelodysplastic Syndrome

University of Washington

Phase 1 Completed
24 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00002798 2013-01-16

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Completed
880 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡